207940.KS
Samsung Biologics Co.,Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 1,477,000.00
−1.60%Next report
Analyst consensus
- Next report date
- Oct 27, 2026
- EPS estimate
- KRW 10.0K
- Revenue estimate
- KRW 1.34T
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- KRW 9.3K
- EPS estimate
- KRW 9.7K
- Revenue actual
- KRW 1.32T
- Revenue estimate
- KRW 1.31T
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.9%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026